These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34114100)

  • 1. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
    Ameri M; Ao Y; Lewis H
    AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
    Kommareddy S; Baudner BC; Bonificio A; Gallorini S; Palladino G; Determan AS; Dohmeier DM; Kroells KD; Sternjohn JR; Singh M; Dormitzer PR; Hansen KJ; O'Hagan DT
    Vaccine; 2013 Jul; 31(34):3435-41. PubMed ID: 23398932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
    Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
    Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term stability of influenza vaccine in a dissolving microneedle patch.
    Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
    Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
    Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
    Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
    J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
    Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
    Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
    PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine.
    Choi IJ; Kang A; Ahn MH; Jun H; Baek SK; Park JH; Na W; Choi SO
    J Control Release; 2018 Sep; 286():460-466. PubMed ID: 30102940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
    Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
    J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal influenza immunization with vaccine-coated microneedle arrays.
    Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
    PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
    Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs.
    Bonificio A; Ghartey-Tagoe E; Gallorini S; Baudner B; Chen G; Singh P; O'Hagan DT; Kommareddy S
    Vaccine; 2015 Jun; 33(25):2930-8. PubMed ID: 25930118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
    Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    Pharm Res; 2011 Jan; 28(1):135-44. PubMed ID: 20387097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.